Company continues to advance CYWC628 manufacturing with second GMP drug product run released for shipment to Australia …
Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated dos…
Watch for follow-on moves from competitors and reactions from key channel partners in the coming quarters.
Koi Peptides introduces the Wolverine Peptide Stack, a research-use-only blend featuring BPC-157 + TB-500, with per-bat…
Koi Peptides introduces Klow Peptide Stack for 2026 research use with GHK-Cu, BPC-157, TB-500, and KPV, HPLC testing, M…
Randomized, double-blind, placebo-controlled, dose-ranging trial evaluating three once-daily oral doses of BGE-102 in p…
IND enabling studies with CLD-401 to continue with IND submission targeted by end of 2026 as Calidi continues to explor…
One family’s generosity is helping drive a major breakthrough in rare cancer research at the MUHC.
Une famille soutient la recherche sur les cancers rares par l’intermédiaire de la Fondation du CUSM
Le King Faisal Specialist Hospital présente la chirurgie robotique comme modèle de soins spécialisés axés sur l’innovat…
Das King Faisal Specialist Hospital & Research Centre (KFSH) unterstreicht seine Führungsrolle in der Roboterchirurgie …
King Faisal Specialist Hospital & Research Centre (KFSH) is highlighting its leadership in robotic surgery during its p…
